Please assess the completion status of the following clinical trial:

Trial Title: Adaptive Treatment for Alcohol and Cocaine Dependence

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~1. meet DSM-IV criteria for lifetime cocaine or alcohol dependence and have used cocaine or alcohol in the prior 6 months;~2. be \> 18 years of age;~3. be judged clinically appropriate for IOP (e.g., no current psychotic disorder or evidence of severe dementia, and no acute medical problem requiring inpatient treatment;~4. have no regular IV heroin use during the past year;~5. have access to a telephone;~6. be willing to be randomized and participate in research; and~7. no current participation in methadone or other forms of DA treatment, other than IOP. Finally, because of study follow-up requirements, subjects will~8. be required to be metropolitan area residents, and~9. be able to provide the name, verified telephone number, and address of at least two contacts who can provide locator information on the patient during follow-up. We will include patients with dependence on other substances, provided that they are cocaine dependent and meet other inclusion criteria.~Exclusion Criteria:~1. have a current psychotic disorder (as assessed with the psychotic screen from the MINI) or evidence of dementia severe enough to prevent participation in outpatient treatment;~2. have acute medical problem requiring immediate inpatient treatment; or~3. are currently participating in methadone or other forms of DA treatment, other than IOP.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 1-MI-IOP Engaged (Type: ACTIVE_COMPARATOR): Randomized to treatment as usual, and they attend regularly but dropped out of treatment after randomization.
- 2-MI-IOP Non-Engaged (Type: EXPERIMENTAL): Randomized to treatment as usual, and do not attend.
- 3-MI-PC Engaged (Type: ACTIVE_COMPARATOR): Randomized to treatment choice, but remain attending treatment as usual then dropped out of treatment after randomization.
- 4-MI-PC Non-engaged (Type: EXPERIMENTAL): Randomized to treatment choice, and do not attend treatment as usual, so the choice option is used.

Based on this trial design, predict the completion outcome and termination type (if applicable).